Stem Cell Sciences and partner streamline portfolios with swap.

LONDON -- Stem Cell Sciences plc has agreed on a technology swap and buy-back deal with its investee company Stem Cell Sciences KK, of Kobe, Japan, to simplify their respective portfolios and allow each to concentrate on particular areas.

"The real push is simplification in terms of focus and effort," Hugh Ilyine, chief operating officer, told BioWorld International. "When we set up [Stem Cell Sciences KK] in 2002, we couldn't imagine where it would take us, and how the companies would develop. They are now creating their own destiny."

Stem Cell Sciences plc seed funded formation of the Japanese operation in collaboration with the Ministry of Health, the City of Kobe …